Corrigendum to “Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo”

Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Richard G. Carroll, Gwendolyn K. Binder, David Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana, James L. Riley, Stephan A. Grupp and Carl H. June

Molecular Therapy (2009) 17: 1453–1464; doi:10.1038/mt.2009.83

The order of variable heavy (VH) and variable light chain (VL) domains of the anti-CD19 scFv depicted in the schematic of Figure 1a were reversed from the actual orientation used. The order of the domains should be VL followed by VH.